Where does KaloCyte's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across KaloCyte's 1 recorded funding rounds.

Premier Alternatives

KaloCyte

Biotechnology · Baltimore, MD · Privately Held (backing)

Developer of a red blood cell substitute designed to support oxygen delivery in trauma care settings. KaloCyte is based in Baltimore, MD. It was valued at $24.7 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $5.7 million across 1 recorded round; the latest was an accelerator round in Jan 2020.

PMV mark · valuation

$24.7M

Oct 2026

Priced at

its later-stage round

Jun 2025

Total raised

$5.7M

Last round

Accelerator/Incubator

Jan 2020

Cap table — not yet on record

KaloCyte's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of KaloCyte with a free account

·The complete investor list: 21 names
·Watch KaloCyte: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about KaloCyte

Where does KaloCyte's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across KaloCyte's 1 recorded funding rounds.